Wellgistics Health CEO Tim Canning to Exit, Brian Norton Named Successor

Dow Jones

03-05

By Sabela Ojea

Wellgistics Health said Chief Executive Tim Canning is leaving after about a year in the role and will be succeeded by Brian Norton.

The holding company centered around pharmaceuticals and healthcare services on Tuesday said that the appointment of Norton comes at a pivotal time for the company as it continues to streamline operations and expand market reach.

Under his leadership, the company will focus on enhancing operational efficiencies, optimizing sales and marketing strategies, advancing its technology roadmap, and remaining disciplined in executing on acquisition opportunities.

Norton has a proven track record of success and expertise in healthcare, technology, and pharmaceutical supply chain innovation and has led high-performing teams to accelerate market growth and revenue recognition, the company said.

Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix

(END) Dow Jones Newswires

March 04, 2025 17:35 ET (22:35 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2517898778"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2517898778\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2517898778?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-05 06:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2517898778","market":"other","top_or_hot":-1,"title":"Wellgistics Health CEO Tim Canning to Exit, Brian Norton Named Successor","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Sabela Ojea \n</p>\n<pre>\n \n</pre>\n<p>\n  Wellgistics Health said Chief Executive Tim Canning is leaving after about a year in the role and will be succeeded by Brian Norton. \n</p>\n<p>\n  The holding company centered around pharmaceuticals and healthcare services on Tuesday said that the appointment of Norton comes at a pivotal time for the company as it continues to streamline operations and expand market reach. \n</p>\n<p>\n  Under his leadership, the company will focus on enhancing operational efficiencies, optimizing sales and marketing strategies, advancing its technology roadmap, and remaining disciplined in executing on acquisition opportunities. \n</p>\n<p>\n  Norton has a proven track record of success and expertise in healthcare, technology, and pharmaceutical supply chain innovation and has led high-performing teams to accelerate market growth and revenue recognition, the company said. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 04, 2025 17:35 ET (22:35 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wellgistics Health CEO Tim Canning to Exit, Brian Norton Named Successor</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWellgistics Health CEO Tim Canning to Exit, Brian Norton Named Successor\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-03-05 06:35</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Sabela Ojea \n</p>\n<pre>\n \n</pre>\n<p>\n  Wellgistics Health said Chief Executive Tim Canning is leaving after about a year in the role and will be succeeded by Brian Norton. \n</p>\n<p>\n  The holding company centered around pharmaceuticals and healthcare services on Tuesday said that the appointment of Norton comes at a pivotal time for the company as it continues to streamline operations and expand market reach. \n</p>\n<p>\n  Under his leadership, the company will focus on enhancing operational efficiencies, optimizing sales and marketing strategies, advancing its technology roadmap, and remaining disciplined in executing on acquisition opportunities. \n</p>\n<p>\n  Norton has a proven track record of success and expertise in healthcare, technology, and pharmaceutical supply chain innovation and has led high-performing teams to accelerate market growth and revenue recognition, the company said. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 04, 2025 17:35 ET (22:35 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4175","symbol_name":"保健护理产品经销商","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2517898778","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2517898778","pubTimestamp":1741127700,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Wellgistics Health said Chief Executive Tim Canning is leaving after about a year in the role and will be succeeded by Brian Norton.The holding company centered around pharmaceuticals and healthcare services on Tuesday said that the appointment of Norton comes at a pivotal time for the company as it continues to streamline operations and expand market reach.Under his leadership, the company will focus on enhancing operational efficiencies, optimizing sales and marketing strategies, advancing its technology roadmap, and remaining disciplined in executing on acquisition opportunities.Norton has a proven track record of success and expertise in healthcare, technology, and pharmaceutical supply chain innovation and has led high-performing teams to accelerate market growth and revenue recognition, the company said.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4175":"保健护理产品经销商","BK4132":"无线电信业务","TIMB":"TIM","WGRX":"Wellgistics Health Inc."},"translate_title":"Wellgistics Health首席执行官蒂姆·坎宁(Tim Canning)退出，布莱恩·诺顿(Brian Norton)被任命为继任者","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TIMB":1,"WGRX":1},"content_text":"By Sabela Ojea \n\n\n \n\n\n  Wellgistics Health said Chief Executive Tim Canning is leaving after about a year in the role and will be succeeded by Brian Norton. \n\n\n  The holding company centered around pharmaceuticals and healthcare services on Tuesday said that the appointment of Norton comes at a pivotal time for the company as it continues to streamline operations and expand market reach. \n\n\n  Under his leadership, the company will focus on enhancing operational efficiencies, optimizing sales and marketing strategies, advancing its technology roadmap, and remaining disciplined in executing on acquisition opportunities. \n\n\n  Norton has a proven track record of success and expertise in healthcare, technology, and pharmaceutical supply chain innovation and has led high-performing teams to accelerate market growth and revenue recognition, the company said. \n\n\n \n\n\n  Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 04, 2025 17:35 ET (22:35 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":1}}}